Syracuse

Regenerative medicine for digestive fistulae therapy : benefits, challenges and promises of stem/stromal cells and emergent perspectives via their extracellular vesicles

Archive ouverte

Sebbagh, Anna C. | Rosenbaum, Boris | Péré, Guillaume | Alric, Hadrien | Berger, Arthur | Wilhelm, Claire | Gazeau, Florence | Mathieu, Noëlle | Rahmi, Gabriel | K. A. Silva, Amanda

Edité par CCSD ; Elsevier -

International audience. Despite current management strategies, digestive fistulae remain extremely debilitating complications associated with significant morbidity and mortality, generating a need to develop innovative therapies in these indications. A number of clinical trials and experimental studies have thus investigated the potential of stem/stromal cells (SCs) or SC-derived extracellular vesicles (EVs) administration for post-surgical and Crohn's-associated fistulae. This review summarizes the physiopathology and current standards-of-care for digestive fistulae, along with relevant evidence from animal and clinical studies regarding SC or EV treatment for post-surgical digestive fistulae. Additionally, existing preclinical models of fistulizing Crohn's disease and results of SC therapy trials in this indication will be presented. The optimal formulation and administration protocol of SC therapy products for gastrointestinal fistula treatment and the challenges for a widespread use of darvadstrocel (Alofisel) in clinical practice will be discussed. Finally, the potential advantages of EV therapy and the obstacles towards their clinical translation will be introduced.

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion